---------------------------------------------------------
FDA approves new COVID-19 vaccines for seniors
By Rena Rowe, Washington Examiner, Published August 28, 2026 9:32am ET
"The Food and Drug Administration on Thursday approved COVID-19 vaccines for the 2026-27 season for people at higher risk of severe illness, including everyone 65 and older and younger people with certain underlying health conditions.
"The FDA approved Moderna’s vaccine for people ages 6 months and older, Pfizer’s for those ages 5 and older, and Sanofi’s for people ages 12 and older. The agency also approved a lower-dose Moderna vaccine, mNEXSPIKE, for people ages 12 and up
"The FDA estimated last year that between 30% and 60% of Americans have a condition that could qualify them for vaccination. Qualifying conditions include asthma, diabetes, obesity, physical inactivity, and pregnancy, as well as cancer, immune deficiencies, certain mental illnesses, and various heart and lung diseases."

No comments:
Post a Comment